Read + Share
Amedeo Smart
Independent Medical Education
Zhang J, Wu Z, Wang S, Sun Y, et al. Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancer. BMC Cancer 2025;25:1070.PMID: 40596985
Email
LinkedIn
Privacy Policy